The company is boosting 2026 spending on its R&D pipeline and clinical trial activities, indicating a strategic push to develop and launch new solutions.
Filing excerpt
In 2026, we expect to incur increased expenses related to commercial expansion, research and development efforts and increase in pipeline trial activities.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qproductLaunchGet every 10-Q signal for Caris Life Sciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/5ada2d19-d7e8-43c7-82f8-3f9b591fb22d returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.
{
"signal_id": "5ada2d19-d7e8-43c7-82f8-3f9b591fb22d",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-08-11T08:09:08.027+00:00",
"company": {
"name": "Caris Life Sciences",
"domain": "carislifesciences.com"
},
"data": {
"detail": "The company is boosting 2026 spending on its R&D pipeline and clinical trial activities, indicating a strategic push to develop and launch new solutions. This creates opportunities for vendors supporting clinical trials, data analysis, and research laboratory operations.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Caris Life Sciences increases investment in R&D and clinical trial pipeline for future solutions.",
"excerpts": "In 2026, we expect to incur increased expenses related to commercial expansion, research and development efforts and increase in pipeline trial activities.",
"relevance": 0.75,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000055/cai-20260630.htm",
"filing_date": "2026-08-05",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/5ada2d19-d7e8-43c7-82f8-3f9b591fb22d \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"carislifesciences.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.